期刊文献+

应用CoMFA及CoMSIA方法研究氮杂环类CCR5拮抗剂的三维定量构效关系 被引量:1

3D-QSAR Studies of Azacycles CCR5 Antagonists Using CoMFA and CoMSIA Methods
下载PDF
导出
摘要 采用比较分子场分析(CoMFA)和比较分子相似性指数分析(CoMSIA)的方法研究氮杂环类CC趋化因子受体5(CCR5)拮抗剂的三维定量构效关系(3D-QSAR),并建立了相应的3D-QSAR模型。结果表明:采用这2种方法建立的3D-QSAR模型对该类化合物具有良好的预测能力(CoMFA:交叉验证系数q^2=0.644,相关系数r^2=0.974;CoMSIA:交叉验证系数q^2=0.553,相关系数r^2=0.822)。根据等值面图分析得出:氮杂环类CCR5拮抗剂的疏水基团及强吸电子基团可以增强其抗病毒活性,有助于设计活性更好的氮杂环类CCR5拮抗剂。 The three-dimensional quantitative structure-activity relationship (3D-QSAR) models of azacyles CCR5 antagonists were developed using comparative molecular field analysis (CoMFA) and comparative molecular similarity indices analysis (CoMSIA) methods. The 3D-QSAR models were shown to have excellent prediction ( CoMFA : the cross-validation coefficient q^2 = 0. 644, and the correlation coefficient r^2 = 0. 974, CoMSIA: the cross-validation coefficient q^2 = 0. 553, and the correlation coefficient r^2= 0. 822). 3D contour maps suggested that hydrophobic substituents and electron- withdrawing groups on the core part would decrease antiviral activity. This study may help to design novel selective antagonists of CCR5 with desired activity.
出处 《重庆理工大学学报(自然科学)》 CAS 2013年第5期48-53,F0003,共7页 Journal of Chongqing University of Technology:Natural Science
基金 国家自然科学基金资助项目(60873103 81171508 31170747 30830090)
  • 相关文献

参考文献20

  • 1Mebatsion T, Finke S, Weiland F, et al. A CXCR4/CIM pseudotype rhabdovirus that selectively infects HIV-1 en-velope protein-expressing cells [ J ]. Cell, 1997,90 ( 5 ) : 841 - 847.
  • 2Azenshtein E, Luboshits G, Shina S, et al. The CC chemo- kine RANTES in breast carcinoma progression:regulation of expression and potential mechanisms of promalignant activity[ J]. Cancer Res, 2002,62(4) :1093 - 1102.
  • 3Tang K F,Tan S Y,Chan S H,et al. A distinct expression of CC chemokines by macrophages in nasopharyngeal car- cinoma[J]. Hum Pathol,2001,32( 1 ) :42 -49.
  • 4Yoong K F, Mford S C, Jones R, et al. Expression and function of CXC and CC chemokines in human malignant liver tumors [ J ]. Hepatotogy, 1999,30 ( 1 ) : 100 - 111.
  • 5Negus R P M, Cordon W, Joanna H, et al. Quantitative assessment of the leukocyte infiltrate in ovarian cancer and its relationship to the expression of CC chemokine [ J ]. American Journal of Pathology, 1997,150 (5) : 1723 - 1734.
  • 6Wang J M, Deng X, Gong W, et al. Chemokines and their role in tumor growth and metastasis [ J ]. J Immunol Meth- ods, 1998,220(12) : 1 - 17.
  • 7Yang Y F, Mukai T, Gao P, et al. A non-peptide CCR5 antagonist inhibits collagen-induced arthritis by modula- ting T cell migration without affecting anti-collagen T cell responses [ J ]. Eur J Immun,2002,32 (8) :2124 - 2132.
  • 8Vierboom M P, Zavodny P J, Chou C C, et al. Inhibition of the development of collagen-induced arthritis in rhesus monkeys by a small molecular weight antagonist of CCR5 [J]. Arth Rheum, 2005,52(2) :627 -636.
  • 9Baba M, Nishimura O, Kanzaki N, et al. A small-mole- ctde, nonpeptide CCR5 antagonist with highly potent and selective anti-HIV-1 activity [ J ]. Medical Sciences, 1999, 96(10) :5698 - 5703.
  • 10Seto T, Funa H, Imamura F, et al. Prognostic value of ex- pression of vascular endothelial growth factor and its fit-1 and KDR receptors in stage I non-small-cell lung cancer [J]. Lung Cancer,2006,53( 1 ) :91 -96.

同被引文献5

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部